Related Experiment Videos
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy
1Liver Research Unit, Medical College, Chang Gung University, Taipei, Taiwan. liveryfl@so-net.net.tw
Journal of Gastroenterology and Hepatology
|February 27, 2003
Summary
Hepatitis flares in chronic hepatitis B are driven by immune responses. Higher ALT flares indicate stronger immunity and better HBV clearance, guiding treatment strategies.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection can lead to hepatitis flares, characterized by a significant rise in alanine aminotransferase (ALT) levels.
- These flares are a result of a cytotoxic T lymphocyte (CTL)-mediated immune response against HBV.
Purpose of the Study:
- To analyze the role of ALT levels in categorizing immune response intensity in chronic HBV infection.
- To inform patient selection and timing of therapeutic interventions for improved outcomes.
Main Methods:
- The study defines hepatitis flares based on ALT levels exceeding fivefold the upper limit of normal (ULN).
- It correlates ALT elevation with the vigor of the immune response and clinical outcomes like HBV clearance and HBeAg seroconversion.
Main Results:
- Higher ALT levels signify a more robust immune response and greater HBV clearance, increasing the likelihood of HBV-DNA loss and HBeAg seroconversion.
- An ALT level of fivefold the ULN serves as a critical threshold for classifying immune response intensity.
Conclusions:
- Understanding hepatitis flare mechanisms is crucial for effective HBV management.
- Tailoring immunomodulatory or antiviral therapies based on ALT levels and immune response is key to preventing hepatic decompensation and improving treatment success.